Vytrus Biotech, S.A. (BME:VYT)
Spain flag Spain · Delayed Price · Currency is EUR
4.900
-0.100 (-2.00%)
At close: Jul 18, 2025, 5:30 PM CET

Vytrus Biotech Statistics

Total Valuation

Vytrus Biotech has a market cap or net worth of EUR 36.87 million. The enterprise value is 36.11 million.

Market Cap36.87M
Enterprise Value 36.11M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Vytrus Biotech has 7.52 million shares outstanding. The number of shares has increased by 11.71% in one year.

Current Share Class 7.52M
Shares Outstanding 7.52M
Shares Change (YoY) +11.71%
Shares Change (QoQ) -0.44%
Owned by Insiders (%) 34.62%
Owned by Institutions (%) 15.28%
Float 3.70M

Valuation Ratios

The trailing PE ratio is 36.11 and the forward PE ratio is 19.78.

PE Ratio 36.11
Forward PE 19.78
PS Ratio 6.05
PB Ratio 5.06
P/TBV Ratio 11.46
P/FCF Ratio 21.15
P/OCF Ratio 20.00
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.68, with an EV/FCF ratio of 20.72.

EV / Earnings 35.37
EV / Sales 5.93
EV / EBITDA 30.68
EV / EBIT 36.66
EV / FCF 20.72

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.24.

Current Ratio 3.03
Quick Ratio 2.60
Debt / Equity 0.24
Debt / EBITDA 1.51
Debt / FCF 1.02
Interest Coverage 8.00

Financial Efficiency

Return on equity (ROE) is 16.23% and return on invested capital (ROIC) is 7.49%.

Return on Equity (ROE) 16.23%
Return on Assets (ROA) 6.02%
Return on Invested Capital (ROIC) 7.49%
Return on Capital Employed (ROCE) 9.97%
Revenue Per Employee 164,605
Profits Per Employee 27,595
Employee Count37
Asset Turnover 0.60
Inventory Turnover 1.07

Taxes

Income Tax -119,270
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +55.52% in the last 52 weeks. The beta is 0.15, so Vytrus Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.15
52-Week Price Change +55.52%
50-Day Moving Average 3.90
200-Day Moving Average 2.83
Relative Strength Index (RSI) 75.25
Average Volume (20 Days) 4,887

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Vytrus Biotech had revenue of EUR 6.09 million and earned 1.02 million in profits. Earnings per share was 0.14.

Revenue6.09M
Gross Profit 5.50M
Operating Income 984,986
Pretax Income 901,738
Net Income 1.02M
EBITDA 1.18M
EBIT 984,986
Earnings Per Share (EPS) 0.14
Full Income Statement

Balance Sheet

The company has 2.53 million in cash and 1.77 million in debt, giving a net cash position of 756,325 or 0.10 per share.

Cash & Cash Equivalents 2.53M
Total Debt 1.77M
Net Cash 756,325
Net Cash Per Share 0.10
Equity (Book Value) 7.29M
Book Value Per Share 0.97
Working Capital 2.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.84 million and capital expenditures -100,999, giving a free cash flow of 1.74 million.

Operating Cash Flow 1.84M
Capital Expenditures -100,999
Free Cash Flow 1.74M
FCF Per Share 0.23
Full Cash Flow Statement

Margins

Gross margin is 90.28%, with operating and profit margins of 16.17% and 16.76%.

Gross Margin 90.28%
Operating Margin 16.17%
Pretax Margin 14.81%
Profit Margin 16.76%
EBITDA Margin 19.33%
EBIT Margin 16.17%
FCF Margin 28.62%

Dividends & Yields

Vytrus Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.71%
Shareholder Yield n/a
Earnings Yield 2.77%
FCF Yield 4.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Vytrus Biotech has an Altman Z-Score of 3.76 and a Piotroski F-Score of 7.

Altman Z-Score 3.76
Piotroski F-Score 7